Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes

Brian TomlinsonResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, China;Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong KongView further author information

Miao HuDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong KongView further author information

Yuzhen ZhangResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, ChinaView further author information

Paul ChanDivision of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, TaiwanCorrespondence[email protected]
View further author information

Zhong-Min LiuDepartment of Cardiac Surgery, Shanghai East Hospital, Tongji University, Shanghai, ChinaCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Declaration of interest

B Tomlinson has received research funding from Amgen, AstraZeneca, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer and Roche. B Tomlinson has served as a consultant/advisor/speaker for Amgen, AstraZeneca, Merck Serono and Sanofi. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes

Information for

Open access

Opportunities

Help and information

Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes

Declaration of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature